AbbVie and Iambic Announce Collaboration to Accelerate AI-Driven Drug Discovery
ABBV•AbbVie and Iambic announce collaboration
AbbVie Inc. and Iambic announced a collaboration to accelerate AI-driven drug discovery.
- The partnership is intended to accelerate small-molecule drug discovery in immunology, neuroscience and oncology.
- Iambic will receive an upfront payment, milestone payments and tiered royalties from the collaboration.
